| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±3.5% | -8.6% | under-priced |
| 04/30/2026 | ±2.8% | -0.3% | over-priced |
| 02/12/2026 | ±2.5% | -0.1% | over-priced |
| 10/30/2025 | ±1.6% | +3.1% | under-priced |
| 07/24/2025 | ±1.7% | +1.3% | over-priced |
| 04/24/2025 | ±2.5% | -0.0% | over-priced |
| 02/14/2025 | ±2.5% | -1.2% | over-priced |
| 10/25/2024 | ±1.4% | +3.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $3.13 | $5.9B | $600M |
| Q1 FY2026 | $2.72 | $5.7B | $512M |
| Q4 FY2025 | — | $21.9B | $300M |
| Q3 FY2025 | $2.46 | $5.7B | $462M |
LHX (LHX) reports in 3 days, with the next report estimated for 10/30/2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 2.3% on average — the market has been roughly fair on LHX's earnings risk. Fundamentals into the print: EPS up 28.3% year-over-year, revenue up 8.4%. QuantLogix's live 5-factor engine currently reads LHX as a buy at 69/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →